M4MM
Jazz Pharmaceuticals: The Medical Cannabis Insider Nearing $1B Milestone
DUBLIN – Jazz Pharmaceuticals reported a 20% jump in Q3 2025 sales for its cannabidiol-based epilepsy drug Epidiolex®, pushing the product's YTD revenue past $772 million and underscoring the company's steady position in the medical ...
Medicare Explores CBD Coverage for Seniors
WASHINGTON – The Centers for Medicare & Medicaid Services (CMS) is set to roll out a pilot program that could extend coverage to cannabidiol (CBD) treatments for certain older Americans, marking a cautious step by ...
How to Make the Most of MJBizCon? Take Full Advantage of LinkedIn
LOS ANGELES- Each year, the global Cannabis industry converges on Las Vegas for MJBizCon Dec 2-5 in the Las Vegas Convention Center—a concentrated, high-value moment where operators, investors, executives, retailers, lenders, lawyers, accountants, manufacturers, and ...
Tilray Brands Reports Fiscal Q1 2026 Earnings
NEW YORK – Tilray Brands Inc. swung to a profit in its fiscal first quarter, fueled by record revenue and sharper cost management, as the Cannabis company builds on a multiyear turnaround. For the period ...
Cannabis Debt Yields Show Wide Gaps Among Top Operators, Viridian Analysis Finds
LOS ANGELES – A fresh assessment of credit profiles among leading U.S. Cannabis companies points to notable discrepancies in debt pricing that could signal untapped value for savvy investors and fixed-income players. Viridian Capital Advisors ...
DMT Reveals Promising Potential in Stroke Recovery, Study Finds
LOS ANGELES – A compound long associated with visionary experiences in plants like ayahuasca may hold untapped value in treating one of medicine's toughest challenges: brain damage from strokes. Hungarian researchers report that N,N-dimethyltryptamine, or ...
Canopy Growth Shifts DOJA Site to Medical-Only Production in Canada
SMITHS FALLS, ON – Canopy Growth Corporation has repurposed its DOJA cultivation facility in Kelowna, British Columbia, to focus solely on medical Cannabis. The change positions the site as a dedicated supplier for its Spectrum ...
Jazz Pharmaceuticals: The Medical Cannabis Insider Nearing $1B Milestone
DUBLIN – Jazz Pharmaceuticals reported a 20% jump in Q3 2025 sales for its cannabidiol-based epilepsy drug Epidiolex®, pushing the product's YTD revenue past $772 million and underscoring the company's steady position in the medical ...
Medicare Explores CBD Coverage for Seniors
WASHINGTON – The Centers for Medicare & Medicaid Services (CMS) is set to roll out a pilot program that could extend coverage to cannabidiol (CBD) treatments for certain older Americans, marking a cautious step by ...
How to Make the Most of MJBizCon? Take Full Advantage of LinkedIn
LOS ANGELES- Each year, the global Cannabis industry converges on Las Vegas for MJBizCon Dec 2-5 in the Las Vegas Convention Center—a concentrated, high-value moment where operators, investors, executives, retailers, lenders, lawyers, accountants, manufacturers, and ...
Cresco Labs Reports Q2 2024 Financial Results
LOS ANGELES- Cresco Labs Inc. has released its financial results for the second quarter of 2024, showcasing significant improvements in profitability and maintaining strong market positions across several states. Key highlights from the report include: ...
Missouri Division of Cannabis Regulation Recalls Over 2,600 Products for Inadequate Testing
LOS ANGELES- The Missouri Division of Cannabis Regulation (DCR) announced a recall on Tuesday for 2,649 cannabis products sold by NGWMO, LLC to dispensary facilities. The recall was issued because the products did not undergo ...
Aurora Cannabis Reports Q1 Fiscal 2025 Financial Results
LOS ANGELES- Aurora Cannabis has announced its financial results for the first quarter of fiscal 2025, ending June 30, 2024. The company reported positive free cash flow, increased revenue, and substantial growth in its global ...
DEA’s Proposed Rescheduling of Cannabis Sparks Public Response
LOS ANGELES- The Drug Enforcement Administration (DEA) has proposed rescheduling cannabis under federal drug law, moving it from Schedule I to Schedule III. This shift reflects changing perceptions about cannabis, which is currently classified alongside ...
Trulieve Reports Q2 2024 Financial Results
LOS ANGELES- Trulieve announced its financial results for the second quarter ending June 30, 2024. The results, reported in U.S. dollars and following U.S. Generally Accepted Accounting Principles (GAAP), reflect continued growth and operational expansion. ...
NYC Crackdown on Illegal Cannabis Shops Shutters 3,000, Creating Opportunities for Legal Retailers
LOS ANGELES- New York City has intensified its efforts to close nearly 3,000 unlicensed cannabis dispensaries, a move that could provide a boost for legal retailers struggling with high rents and intense competition. Since the ...
The Battle Over Recreational Cannabis Legalization Heats Up
LOS ANGELES- The debate around legalizing recreational cannabis continues to draw support and opposition from various societal factions. Central to this contentious issue is a push to amend state laws to allow adults aged 21 ...
Missouri Governor Signs Executive Order to Ban Intoxicating Hemp Product Sales
LOS ANGELES- Missouri Governor Mike Parson has signed an executive order banning the sale of intoxicating, hemp-derived products in the state, effective September 1. The order prohibits the sale of hemp-derived products containing delta-8 and ...
NEWS: Ohio Dispensaries Set to Begin Recreational Cannabis Sales
CLEVELAND- Starting Tuesday, Ohioans aged 21 and over will have the opportunity to purchase recreational cannabis without needing a medical card. This marks a significant change in the state's cannabis regulations. The Ohio Department of ...
Government Survey Data Shows Nearly 20 Percent Decline in Teen Cannabis Use Over Past Decade
LOS ANGELES- Government survey data released today by the US Department of Health and Human Services confirms that state-specific cannabis legalization laws have not negatively impacted teen cannabis use rates. The latest National Survey on ...
Ohio to Launch Recreational Cannabis Sales
LOS ANGELES- Ohio will commence recreational cannabis sales early next week, possibly as soon as Tuesday, August 6, following the issuance of the first necessary licenses on Monday. Jamie Crawford, Public Information Officer for Ohio’s ...
MindBio Reports Sustained Antidepressant Effects from Microdosing LSD in Phase 2A Depression Trials
LOS ANGELES- MindBio Therapeutics Corp. a Vancouver-based biopharmaceutical company, has announced promising durability data from its Phase 2A clinical trials testing MB22001, a proprietary microdosed LSD treatment for depression. The study, which involved self-administered, take-home ...
Ascend Wellness Stock Rises Amid Major Debt Refinancing Deal
LOS ANGELES- Ascend Wellness Holdings, Inc. saw its stock price increase by 2.9% on Friday, trading as high as $1.07 before closing at the same price. This trading activity represented a 301% increase in volume, ...
Tilray Expands Medical Cannabis Portfolio in Portugal
LOS ANGELES- Tilray Brands, Inc. has announced a new achievement in its European medical cannabis operations. The company received approval for its new product, Tilray Solução Oral THC10, in Portugal. This follows earlier approvals for ...
Philippine Lawmakers Push for Medical Cannabis Legalization
LOS ANGELES- The Philippines is making another attempt to legalize medical cannabis, with the House of Representatives approving a new bill on Tuesday. The measure, passed by a vote of 177-9, seeks to establish a ...
